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GUIDELINES
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This is one of a series of BMJ summaries of new guidelines based on
the best available evidence; they highlight important recommendations
for clinical practice, especially where uncertainty or controversy exists.
Social anxiety disorder is one of themost persistent and common
of the anxiety disorders, with lifetime prevalence rates in Europe
of 6.7% (range 3.9-13.7%).1 It often coexists with depression,
substance use disorder, generalised anxiety disorder, panic
disorder, and post-traumatic stress disorder.2 It can severely
impair a person’s daily functioning by impeding the formation
of relationships, reducing quality of life, and negatively affecting
performance at work or school. Despite this, and the fact that
effective treatments exist, only about half of people with this
condition seek treatment, many after waiting 10-15 years.3
Although about 40% of those who develop the condition in
childhood or adolescence recover before adulthood,4 for many
the disorder persists into adulthood, with the chance of
spontaneous recovery then limited compared with other mental
health problems.
This article summarises the most recent recommendations from
the National Institute for Health and Care Excellence (NICE)
on recognising, assessing, and treating social anxiety disorder
in children, young people, and adults.5
Recommendations
NICE recommendations are based on systematic reviews of the
best available evidence and explicit consideration of cost
effectiveness. When minimal evidence is available,
recommendations are based on the Guideline Development
Group’s experience and opinion of what constitutes good
practice. Evidence levels for the recommendations are given in
italic in square brackets.
Principles for working with all people with
social anxiety disorder
• When a person is first offered an appointment, provide
clear information in a letter about:
-Where to go on arrival and where they can wait (offer the
use of a private waiting area or the option to wait
elsewhere—for example, outside the service’s premises)
-Location of facilities available at the service (for example,
the car park and toilets)
-What will happen and what will not happen during
assessment and treatment.
When the person arrives for the appointment, offer to meet them
or alert them (for example, by text message) when their
appointment is about to begin. [Based on the experience and
opinion of the Guideline Development Group (GDG) and on
evidence reviewed in two recent NICE guidelines on mental
health6 7 ]
• Offer to provide treatment in settings where children and
young people and their parents or carers feel most
comfortable—for example, at home or in schools or
community centres. [Based on the experience and opinion
of the GDG]
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Identification of adults with possible social
anxiety disorder
• Ask the identification questions using the two-item
generalised anxiety disorder scale (GAD-2)8 in line with
NICE guidance6, and if social anxiety disorder is suspected:
-Use the three-item mini-social phobia inventory
(Mini-SPIN)9 or
-Consider asking the following two questions: Do you find
yourself avoiding social situations or activities? Are you
fearful or embarrassed in social situations?
If the person scores 6 or more on the Mini-SPIN or answers yes
to either of the two questions above, refer for or conduct a
comprehensive assessment for social anxiety disorder.
[Based on a systematic review of assessment tools and the
experience and opinion of the GDG]
Identification of children and young people
with possible social anxiety disorder
Professionals in primary care and education and in community
settings should be alert to possible anxiety disorders in children
and young people, particularly those who avoid school, social
or group activities, or talking in social situations, or are irritable,
excessively shy, or overly reliant on parents or carers. Consider
asking the child or young person (or their parents or carers)
about their feelings of anxiety, fear, avoidance, distress, and
associated behaviours, to help establish if social anxiety disorder
is present, using the following statement and questions:
“Sometimes people get very scared when they have to do
things with other people, especially people they don’t know.
They might worry about doing things with other people
watching. They might get scared that they will do something
silly or that people will make fun of them. They might not
want to do these things or, if they have to do them, they
might get very upset or cross.” Then ask:
-“Do you/does your child get scared about doing things with
other people, like talking, eating, going to parties, or other
things at school or with friends?”
-“Do you/does your child find it difficult to do things when
other people are watching, like playing sport, being in plays
or concerts, asking or answering questions, reading aloud,
or giving talks in class?”
-“Do you/does your child ever feel that you/your child can’t
do these things or tries to get out of them?”
[Based on the experience and opinion of the GDG]
If the child or young person or parents or carers answer “yes”
to one or more of the questions consider a comprehensive
assessment for social anxiety disorder. [Based on the experience
and opinion of the GDG]
Comprehensive assessment for children,
young people, and adults
• Obtain a detailed description of the person’s current social
anxiety and associated problems and circumstances
including:
-Feared and avoided social situations, and what they are
afraid might happen in social situations (for example,
looking anxious, blushing, sweating, trembling, or
appearing boring)
-Anxiety symptoms
-View of self
-Safety seeking behaviours
-Anticipatory and post-event processing
-Occupational, educational, financial, and social
circumstances in adults
-Family circumstances and support, friendships and peer
groups, educational and social circumstances in children
and young people
-Medication, alcohol, and recreational drug use.
[Based on the experience and opinion of the GDG]
Delivering interventions for children, young
people, and adults
All interventions should be delivered by competent practitioners.
Psychological interventions should be based on the relevant
treatment manual(s), which should guide their structure and
duration. Practitioners should consider using competence
frameworks developed from the relevant treatment manual(s)
and for all interventions should receive regular, high quality,
outcome informed supervision; use routine sessional outcome
measures; and monitor treatment adherence and practitioner
competence (for example, using video and audio recordings,
and external audit and scrutiny if appropriate). [Based on a
systematic review of assessment tools and the experience and
opinion of the GDG]
Interventions for adults with social anxiety
disorder
First line treatment
• Offer adults individual cognitive behavioural therapy
(CBT) that has been specifically developed to treat social
anxiety disorder (based on the Clark and Wells model or
the Heimberg model5). [Based on a systematic review,
network meta-analysis, and an economic model]
• Do not routinely offer group CBT in preference to
individual CBT. Although there is evidence that group
CBT is more effective than most other interventions, it is
less clinically and cost effective than individual CBT.
[Based on a systematic review, network meta-analysis, and
an economic model]
Second line treatments
• For adults who decline CBT and wish to consider another
psychological intervention, offer CBT based, supported
self help.[Based on a systematic review, network
meta-analysis, and an economic model]
• For adults who decline cognitive behavioural interventions
and express a preference for a drug intervention, discuss
their reasons for declining cognitive behavioural
interventions and try to resolve any concerns. [Based on
the experience and opinion of the GDG and on a systematic
review, network meta-analysis, and an economic model]
• If the person wishes to proceed with a drug intervention,
offer a selective serotonin reuptake inhibitor (escitalopram
or sertraline). Monitor carefully for adverse reactions.
[Based on a systematic review, network meta-analysis, and
an economic model]
Third line treatments
• For adults who decline cognitive behavioural interventions
and drug treatment, consider short term, psychodynamic
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psychotherapy specifically developed for social anxiety
disorder. However, bear in mind the more limited clinical
and cost effectiveness of this intervention. [Based on a
systematic review, network meta-analysis, and an economic
model]
The components of the recommended psychological therapies
for adults can be found in the full NICE guideline.5
Interventions for children and young people
with social anxiety disorder
• Offer individual or group CBT focused on social anxiety.
Consider involving parents or carers for effective delivery
of the intervention, particularly in young children. [Based
on a systematic review and meta-analysis]
The components of the recommended psychological therapies
for adults can be found in the full NICE guideline.5
• Do not routinely offer drug interventions to treat social
anxiety disorder in children and young people. [Based on
a systematic review and meta-analysis]
Overcoming barriers
The guideline deals with several potential barriers to people
seeking treatment for social anxiety disorder: people may think
that the social anxiety is part of their personality and cannot be
changed (or, in the case of children, that they will grow out of
it); theymay fear negative evaluation by healthcare professionals
if they disclose their problem; even after presentation, the
disorder may not be recognised by healthcare professionals,
especially in primary care.10 The guideline advises healthcare
professionals to be aware of barriers to people seeking treatment,
and on how to identify the disorder in all age groups and how
services can make themselves more accessible. It also
recommends effective treatments and seeks to help
commissioners identify the services that should be made
available.
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Further information on the guidance
Factors prompting the development of this guideline include the poor recognition and inadequate assessment of social anxiety disorder and
the limited awareness or availability of treatments despite the existence of effective psychological and drug interventions. Social anxiety
disorder is under-recognised in primary care,10 particularly when it coexists with depression. Often the depressive episode may be identified
but the underlying and more persistent social anxiety disorder is not. The early age of onset means that recognition of social anxiety disorder
in educational settings is important and may bring early and lasting benefits to children, but it is challenging to achieve this without accurate
identification and clear referral pathways.
Methods
This guideline was developed by the National Collaborating Centre for Mental Health using NICE guideline methods (www.nice.org.uk/
guidelinesmanual). The guideline review process involved comprehensive and systematic literature searches to identify relevant evidence
for the clinical and economic reviews, with critical appraisal of the quality of the identified evidence. Results of intervention studies were
compared using pairwise and network meta-analysis. Results of the network meta-analysis were used to inform an economic model. A
multidisciplinary team of healthcare professionals from psychiatry, psychology, and general practice and service user and carer representatives
(forming the GDG) was established to review the evidence and develop the subsequent recommendations. The guideline then went through
an external consultation with stakeholders. The GDG considered the stakeholders’ comments, reanalysed the data where necessary, and
modified the guideline as appropriate.
NICE has produced three different versions of the guideline: a full version; a summary version known as the “NICE guideline”; and a version
for children, young people, and adults with social anxiety disorder, their parents and carers, and the public. All these versions, as well as a
pathway, are available from the NICE website. Updates of the guideline will be produced as part of NICE’s guideline development programme.
Areas for future research
• What methods are effective in improving uptake of and engagement with interventions for adults with social anxiety disorder?
• What is the best way of involving parents in the treatment of children and young people with social anxiety disorder at different stages
of development?
• What is the clinical and cost effectiveness of specific CBT for children and young people with social anxiety disorder compared with
generic anxiety focused CBT?
• What is the clinical and cost effectiveness of individual and group CBT for children and young people with social anxiety disorder?
• What is the clinical and cost effectiveness of combined psychological and drug interventions compared with either intervention alone
in treating adults with social anxiety disorder?
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